Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies
Clinical trial NCT00506805 · COMPLETED
Trial details
- NCT number
- NCT00506805
- Sponsor
- Esanex Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2010-03-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.